Grants, prizes and donations
The Knut and Alice Wallenberg Foundation supports life science research at KI
Ten innovation projects in life sciences have received grants within the Knut and Alice Wallenberg Foundation's and SciLifeLab's Proof-of-Concept Program. Four of the projects are run by researchers at Karolinska Institutet. The Proof-of-Concept Program aims to bridge the gap from academic research to innovations in the life sciences.
Eight KI researchers receive grants from the Asthma and Allergy Association's Research Fund
This year, the Asthma and Allergy Association's Research Fund is distributing SEK 8.8 million to important asthma and allergy research. Eight of the researchers who receive grants work at Karolinska Institutet.
The Swedish Cancer and Allergy Fund grants SEK 2.3 million to KI researchers
Cancer- och allergifonden (the Swedish Cancer and Allergy Fund) is awarding a total of SEK 3.6 million to 21 research projects in the field of cancer and allergy. Of these, twelve researchers at Karolinska Institutet will be awarded SEK 2.3 million. The grants aim to promote groundbreaking research that improves the diagnosis, treatment and prevention of cancer and allergies.
Mats Paulsson Foundations allocate SEK 10 million to Alzheimer's research at KI
The Mats Paulsson Foundations award Jan Johansson, professor at the Department of Medicine, Huddinge, Karolinska Institutet, SEK 10 million for research into new innovative treatment methods for Alzheimer's disease. The aim of the research project is to create a new drug that can achieve a breakthrough in the treatment of the most common dementia disease.
The Conversation
Hyperbaric chamber treatment may alleviate PTSD
Post-traumatic stress disorder (PTSD) is common in military veterans but can affect anyone who has suffered or witnessed an extreme physical or emotional event, and it is very hard to treat. Novel treatments are urgently needed. A recent study has been showing promise with an unusual treatment: hyperbaric oxygen therapy (HBOT).
Eight reasons why ADHD diagnoses are increasing
The rate of children diagnosed with ADHD has increased significantly in recent years. In an article in The Conversation, KI Professor Sven Bölte explains why this is the case.
Does psilocybin really provide long-term relief from depression, as new study suggests?
Recent studies suggest that psilocybin, the active compound in magic mushrooms, shows promise as a treatment for depression, with rapid effects. But is the effect long-lasting? Science does not yet have an answer to this question.
More articles from KI researchers published in The Conversation
From cold-resistant genes to face masks, Karolinska Institutet researchers contribute to the global public discourse on a range of topics through our collaboration with the international news site The Conversation.
Selected top publications
New insights into wound healing difficulties in chronic diseases
Zhuang Liu et al, Cell Stem Cell, December 2024
Researchers propose new model for funding pandemic preparedness
Hampus Holmer et al, The Lancet, December 2024
How SARS-CoV-2 exploits human proteins to replicate
McInerney et al, Nature Communications, December 2024
Researchers have created an atlas of human embryo development
Fredrik Lanner et al, Nature Methods, November 2024
HPV screening most effective to reduce cervical cancer
Joakim Dillner et al, The Lancet Public Health, October 2024
More high-impact publications